We’re working to ensure the people who need our medicines have access to them, no matter where they are. Our efforts to expand medication access in underserved regions of the world include innovative pricing and licensing models, community education, outreach campaigns and much more.
We recognize that it takes more than medicine to improve the wellbeing of people worldwide, which is why we partner with organizations aligned in our mission to dissolve barriers to care, particularly in communities who are disproportionately impacted by HIV, cancer, viral hepatitis and other liver diseases.
Diversity in clinical research helps us better understand how our treatments uniquely affect every population. To increase diversity in our clinical trials, we are focused on study site location, study execution and partner selection.
Variable pricing models, coupled with voluntary licensing agreements, allow us to make treatments available to more people in more places faster. We believe our success and ongoing experiences can help ensure the world’s health systems are more resilient.